Patent Amendment (Human Genes and Biological Materials) Bill 2010

9.00am – 10.00am

Peter MacCallum Cancer Centre (Submission 24)
Dr Shari Lofthouse, Manager, Intellectual Property & Development
Dr Gillian Mitchell, Director, Familial Cancer Centre
Walter and Eliza Hall Institute of Medical Research (Submission 59)
Professor Douglas Hilton, Director
Dr Julian Clark, Business Development Manager

10.00am – 10.45am

Royal College of Pathologists of Australasia (Submission 4)
Dr Graeme Suthers, Chair, Genetics Advisory Committee

10.45am – 11.00am

Break

11.00am – 11.45am

Professor Peter Drahos (Submission 25)

11.45am – 12.30pm

Law Council of Australia (Submission 48)
Mr Richard Hamer, Deputy Chairman, Intellectual Property Committee, Business Law Section
Mr Richard Jarvis, Member, Intellectual Property Committee, Business Law Section
Institute of Patent and Trade Mark Attorneys (Submission 49)
Dr Trevor Davies, Councillor, Fellow of IPTA
Dr Tania Obranovich, Fellow of IPTA

12.30pm – 1.30pm

Lunch break

1.30pm – 2.30pm

Medicines Australia (Submission 89)
Dr Brendan Shaw, Chief Executive
Ms Deborah Monk, Director, Innovation and Industry Policy
Mr Tim Murphy, Co-Chair, Innovation Strategic Committee & Head, Government Affairs & Policy, GlaxoSmithKline Australia

2.30pm – 3.15pm

Generics Medicines Industry Association (Submission 71)
Dr Martin Cross, Chairman
Mr Colin Hannah, Board Member

3.15pm – 3.30pm

Break

3.30pm – 4.15pm

Professor Dianne Nicol and Mr Johnathon Liddicoat (Submission 39) (via teleconference)

4.15pm – 5.00pm

Cancer Council Australia (Submission 72)
Professor Ian Olver AM, Chief Executive Officer